Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Amphetamine

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada. 

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada. 

Morin KA, Vojtesek F, Acharya S, Marsh DC. 

Front Psychiatry. 2021 Dec 20;12:782066. doi: 10.3389/fpsyt.2021.782066. PMID: 34987430; PMCID: PMC8721960.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721960/